Found: 231
Select item for more details and to access through your institution.
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
- Published in:
- Journal of Cellular Physiology, 1993, v. 155, n. 3, p. 556, doi. 10.1002/jcp.1041550314
- By:
- Publication type:
- Article
Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 10, p. 1545, doi. 10.1007/s00432-010-0812-0
- By:
- Publication type:
- Article
A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2007, v. 133, n. 12, p. 969, doi. 10.1007/s00432-007-0244-7
- By:
- Publication type:
- Article
Breast conservative therapy in east part of China: a retrospective cohort study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2006, v. 132, n. 9, p. 573, doi. 10.1007/s00432-006-0104-x
- By:
- Publication type:
- Article
Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2007, v. 133, n. 2, p. 83, doi. 10.1007/s00432-006-0140-6
- By:
- Publication type:
- Article
The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2006, v. 132, n. 10, p. 617, doi. 10.1007/s00432-006-0105-9
- By:
- Publication type:
- Article
A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers.
- Published in:
- Scientific Data, 2022, v. 9, n. 1, p. 1, doi. 10.1038/s41597-022-01681-z
- By:
- Publication type:
- Article
Twist-1 Up-Regulation in Carcinoma Correlates to Poor Survival.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 12, p. 21621, doi. 10.3390/ijms151221621
- By:
- Publication type:
- Article
MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ubiquitination/deubiquitination and acetylation/deacetylation: Making DNMT1 stability more coordinated.
- Published in:
- Acta Pharmacologica Sinica, 2011, v. 32, n. 2, p. 139, doi. 10.1038/aps.2011.3
- By:
- Publication type:
- Article
Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 543, doi. 10.1007/s10549-023-07153-1
- By:
- Publication type:
- Article
Ipsilateral breast tumor recurrence after breast-conserving surgery: insights into biology and treatment.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Comments on: a prediction model for distant metastasis after isolated locoregional recurrence of breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 1, p. 97, doi. 10.1007/s10549-022-06708-y
- By:
- Publication type:
- Article
The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 319, doi. 10.1007/s10549-022-06537-z
- By:
- Publication type:
- Article
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 2, p. 371, doi. 10.1007/s10549-020-05940-8
- By:
- Publication type:
- Article
Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 3, p. 561, doi. 10.1007/s10549-020-05660-z
- By:
- Publication type:
- Article
Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 1, p. 225, doi. 10.1007/s10549-018-4956-y
- By:
- Publication type:
- Article
SDF-1 expression and tumorinfiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.940635
- By:
- Publication type:
- Article
Determining the Optimal (Neo)Adjuvant Regimen for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Regarding Survival Outcome: A Network Meta-Analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.919369
- By:
- Publication type:
- Article
p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis.
- Published in:
- International Journal of Cancer, 1997, v. 74, n. 5, p. 529, doi. 10.1002/(SICI)1097-0215(19971021)74:5<529::AID-IJC9>3.0.CO;2-5
- By:
- Publication type:
- Article
Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28452-z
- By:
- Publication type:
- Article
Triple-negative breast cancer: new treatment strategies in the era of precision medicine.
- Published in:
- SCIENCE CHINA Life Sciences, 2021, v. 64, n. 3, p. 372, doi. 10.1007/s11427-020-1714-8
- By:
- Publication type:
- Article
Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231225032
- By:
- Publication type:
- Article
ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 11, p. 7176, doi. 10.1245/s10434-022-11960-z
- By:
- Publication type:
- Article
A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 11, p. 7165, doi. 10.1245/s10434-022-11958-7
- By:
- Publication type:
- Article
Different Patterns in the Prognostic Value of Age for Breast Cancer-Specific Mortality Depending on Hormone Receptor Status: A SEER Population-Based Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 4, p. 1102, doi. 10.1245/s10434-014-4108-5
- By:
- Publication type:
- Article
Clinical and Pathological Response to Neoadjuvant Chemotherapy Based on Primary Tumor Reduction is Correlated to Survival in Hormone Receptor-Positive but not Hormone Receptor-Negative Locally Advanced Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 1, p. 32, doi. 10.1245/s10434-014-3894-0
- By:
- Publication type:
- Article
Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, p. 648, doi. 10.1245/s10434-014-3746-y
- By:
- Publication type:
- Article
Lymph Node Counts and Ratio in Axillary Dissections Following Neoadjuvant Chemotherapy for Breast Cancer: A Better Alternative to Traditional pN Staging.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 1, p. 42, doi. 10.1245/s10434-013-3245-6
- By:
- Publication type:
- Article
Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor-positive Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 9, p. 3002, doi. 10.1245/s10434-012-2318-2
- By:
- Publication type:
- Article
Outcome of Pure Mucinous Breast Carcinoma Compared to Infiltrating Ductal Carcinoma: A Population-based Study from China.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 9, p. 3019, doi. 10.1245/s10434-012-2322-6
- By:
- Publication type:
- Article
Predicting Breast Cancer Recurrence Following Breast-Conserving Therapy: A Single-Institution Analysis Consisting of 764 Chinese Breast Cancer Cases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 9, p. 2492, doi. 10.1245/s10434-011-1626-2
- By:
- Publication type:
- Article
Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 5, p. 1342, doi. 10.1245/s10434-010-1407-3
- By:
- Publication type:
- Article
Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer.
- Published in:
- PLoS Biology, 2018, v. 16, n. 7, p. 1, doi. 10.1371/journal.pbio.2005869
- By:
- Publication type:
- Article
Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.
- Published in:
- Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-00663-1
- By:
- Publication type:
- Article
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study.
- Published in:
- Scientific Reports, 2017, p. 45411, doi. 10.1038/srep45411
- By:
- Publication type:
- Article
A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.
- Published in:
- Scientific Reports, 2016, p. 32585, doi. 10.1038/srep32585
- By:
- Publication type:
- Article
Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin.
- Published in:
- Scientific Reports, 2016, p. 30091, doi. 10.1038/srep30091
- By:
- Publication type:
- Article
Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based Study.
- Published in:
- Scientific Reports, 2016, p. 24037, doi. 10.1038/srep24037
- By:
- Publication type:
- Article
Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40715-x
- By:
- Publication type:
- Article
AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221083956
- By:
- Publication type:
- Article
High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140572
- By:
- Publication type:
- Article
A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0133184
- By:
- Publication type:
- Article
Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0133896
- By:
- Publication type:
- Article
ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114646
- By:
- Publication type:
- Article